OSE Immunotherapeutics SA had a revenue of 69.05M in the quarter ending Jun 30, 2024, with 7845.45%. This bring the company's revenue in the last twelve months to 69.92M, Decreased 3039.43%. In the fiscal year ending Dec 31, 2023, OSE Immunotherapeutics SA had annual revenue of 2.23M with -87.83% growth.